Beryl Drugs informs about compliance certificate

22 Oct 2022 Evaluate
With reference to various conditions stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by the listed Companies, Beryl Drugs has informed that it enclosed the following documents relating to quarter ended on 30.09.2022: Regulation 40(9) - Certificate from Practicing Company Secretary; Reconciliation of Share Capital Audit Report (SEBI- Dp Reg. 55A).

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

31.53 -3.50 (-9.99%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.